United States Antibacterial Drug Resistance Market Report 2017

February 2017 | 117 pages | ID: U9D4C010AF5EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Antibacterial Drug Resistance

Revenue, means the sales value of Antibacterial Drug Resistance

This report studies sales (consumption) of Antibacterial Drug Resistance in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• AAIPharma Services
• ANTABIO
• Abgentis
• Abbott Laboratories
• Absynth Biologics
• Achaogen
• Acino Holdings
• Aventis Pharma
• Austell Laboratories
• Assembly Biosciences
• Arpida
• Demuris
• Evolva Holding
• ContraFect
• Cerexa
• GSK
• InterMune
• Isis Pharmaceuticals
• Lyndra
• Microbecide
• Morphochem
• Nabriva Therapeutics
• NanoSafe Coatings
• Novexel
• Osel
• PENDOPHARM
• Pfizer
• VenatoRx Pharmaceuticals

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Telavancin (Vibativ?)
• Ceftaroline Fosamil (Teflaro? / Zinforo)
• Fidaxomicin (Dificid / Dificlir?)
• Ceftobiprole Medocaril (Zevtera? / Zeftera? / Mabelio?)
• Dalbavancin (Dalvance? / Xydalba?)
• Tedizolid Phosphate (Sivextro?)
• Oritavancin (Orbactiv? / Nuvocid?)
• Ceftolozane-Tazobactam (Zerbaxa?)
• Ceftazidime-Avibactam (Avycaz? / Zavicefta)
• PHASE III DRUGS

Split by applications, this report focuses on sales, market share and growth rate of Antibacterial Drug Resistance in each application, can be divided into

• Gram-Positive
• Gram-Negative

Contents

United States Antibacterial Drug Resistance Market Report 2017

1 ANTIBACTERIAL DRUG RESISTANCE OVERVIEW

1.1 Product Overview and Scope of Antibacterial Drug Resistance
1.2 Classification of Antibacterial Drug Resistance
  1.2.1 Telavancin (Vibativ?)
  1.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
  1.2.3 Fidaxomicin (Dificid / Dificlir?)
  1.2.4 Ceftobiprole Medocaril (Zevtera? / Zeftera? / Mabelio?)
  1.2.5 Dalbavancin (Dalvance? / Xydalba?)
  1.2.6 Tedizolid Phosphate (Sivextro?)
  1.2.7 Oritavancin (Orbactiv? / Nuvocid?)
  1.2.8 Ceftolozane-Tazobactam (Zerbaxa?)
  1.2.9 Ceftazidime-Avibactam (Avycaz? / Zavicefta)
  1.2.10 PHASE III DRUGS
1.3 Application of Antibacterial Drug Resistance
  1.3.1 Gram-Positive
  1.3.2 Gram-Negative
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Antibacterial Drug Resistance (2012-2022)
  1.4.1 United States Antibacterial Drug Resistance Sales and Growth Rate (2012-2022)
  1.4.2 United States Antibacterial Drug Resistance Revenue and Growth Rate (2012-2022)

2 UNITED STATES ANTIBACTERIAL DRUG RESISTANCE COMPETITION BY MANUFACTURERS

2.1 United States Antibacterial Drug Resistance Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Antibacterial Drug Resistance Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Antibacterial Drug Resistance Average Price by Manufactures (2015 and 2016)
2.4 Antibacterial Drug Resistance Market Competitive Situation and Trends
  2.4.1 Antibacterial Drug Resistance Market Concentration Rate
  2.4.2 Antibacterial Drug Resistance Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES ANTIBACTERIAL DRUG RESISTANCE SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Antibacterial Drug Resistance Sales and Market Share by States (2012-2017)
3.2 United States Antibacterial Drug Resistance Revenue and Market Share by States (2012-2017)
3.3 United States Antibacterial Drug Resistance Price by States (2012-2017)

4 UNITED STATES ANTIBACTERIAL DRUG RESISTANCE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Antibacterial Drug Resistance Sales and Market Share by Type (2012-2017)
4.2 United States Antibacterial Drug Resistance Revenue and Market Share by Type (2012-2017)
4.3 United States Antibacterial Drug Resistance Price by Type (2012-2017)
4.4 United States Antibacterial Drug Resistance Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ANTIBACTERIAL DRUG RESISTANCE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Antibacterial Drug Resistance Sales and Market Share by Application (2012-2017)
5.2 United States Antibacterial Drug Resistance Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ANTIBACTERIAL DRUG RESISTANCE MANUFACTURERS PROFILES/ANALYSIS

6.1 AAIPharma Services
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Antibacterial Drug Resistance Product Type, Application and Specification
    6.1.2.1 Telavancin (Vibativ?)
    6.1.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
  6.1.3 AAIPharma Services Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 ANTABIO
  6.2.2 Antibacterial Drug Resistance Product Type, Application and Specification
    6.2.2.1 Telavancin (Vibativ?)
    6.2.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
  6.2.3 ANTABIO Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Abgentis
  6.3.2 Antibacterial Drug Resistance Product Type, Application and Specification
    6.3.2.1 Telavancin (Vibativ?)
    6.3.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
  6.3.3 Abgentis Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Abbott Laboratories
  6.4.2 Antibacterial Drug Resistance Product Type, Application and Specification
    6.4.2.1 Telavancin (Vibativ?)
    6.4.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
  6.4.3 Abbott Laboratories Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Absynth Biologics
  6.5.2 Antibacterial Drug Resistance Product Type, Application and Specification
    6.5.2.1 Telavancin (Vibativ?)
    6.5.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
  6.5.3 Absynth Biologics Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Achaogen
  6.6.2 Antibacterial Drug Resistance Product Type, Application and Specification
    6.6.2.1 Telavancin (Vibativ?)
    6.6.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
  6.6.3 Achaogen Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Acino Holdings
  6.7.2 Antibacterial Drug Resistance Product Type, Application and Specification
    6.7.2.1 Telavancin (Vibativ?)
    6.7.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
  6.7.3 Acino Holdings Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Aventis Pharma
  6.8.2 Antibacterial Drug Resistance Product Type, Application and Specification
    6.8.2.1 Telavancin (Vibativ?)
    6.8.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
  6.8.3 Aventis Pharma Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Austell Laboratories
  6.9.2 Antibacterial Drug Resistance Product Type, Application and Specification
    6.9.2.1 Telavancin (Vibativ?)
    6.9.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
  6.9.3 Austell Laboratories Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Assembly Biosciences
  6.10.2 Antibacterial Drug Resistance Product Type, Application and Specification
    6.10.2.1 Telavancin (Vibativ?)
    6.10.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
  6.10.3 Assembly Biosciences Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Arpida
6.12 Demuris
6.13 Evolva Holding
6.14 ContraFect
6.15 Cerexa
6.16 GSK
6.17 InterMune
6.18 Isis Pharmaceuticals
6.19 Lyndra
6.20 Microbecide
6.21 Morphochem
6.22 Nabriva Therapeutics
6.23 NanoSafe Coatings
6.24 Novexel
6.25 Osel
6.26 PENDOPHARM
6.27 Pfizer
6.28 VenatoRx Pharmaceuticals

7 ANTIBACTERIAL DRUG RESISTANCE MANUFACTURING COST ANALYSIS

7.1 Antibacterial Drug Resistance Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Antibacterial Drug Resistance

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Antibacterial Drug Resistance Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antibacterial Drug Resistance Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ANTIBACTERIAL DRUG RESISTANCE MARKET FORECAST (2017-2022)

11.1 United States Antibacterial Drug Resistance Sales, Revenue Forecast (2017-2022)
11.2 United States Antibacterial Drug Resistance Sales Forecast by Type (2017-2022)
11.3 United States Antibacterial Drug Resistance Sales Forecast by Application (2017-2022)
11.4 Antibacterial Drug Resistance Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antibacterial Drug Resistance
Table Classification of Antibacterial Drug Resistance
Figure United States Sales Market Share of Antibacterial Drug Resistance by Type in 2015
Figure Telavancin (Vibativ?) Picture
Figure Ceftaroline Fosamil (Teflaro? / Zinforo) Picture
Figure Fidaxomicin (Dificid / Dificlir?) Picture
Figure Ceftobiprole Medocaril (Zevtera? / Zeftera? / Mabelio?) Picture
Figure Dalbavancin (Dalvance? / Xydalba?) Picture
Figure Tedizolid Phosphate (Sivextro?) Picture
Figure Oritavancin (Orbactiv? / Nuvocid?) Picture
Figure Ceftolozane-Tazobactam (Zerbaxa?) Picture
Figure Ceftazidime-Avibactam (Avycaz? / Zavicefta) Picture
Figure PHASE III DRUGS Picture
Table Application of Antibacterial Drug Resistance
Figure United States Sales Market Share of Antibacterial Drug Resistance by Application in 2015
Figure Gram-Positive Examples
Figure Gram-Negative Examples
Figure United States Antibacterial Drug Resistance Sales and Growth Rate (2012-2022)
Figure United States Antibacterial Drug Resistance Revenue and Growth Rate (2012-2022)
Table United States Antibacterial Drug Resistance Sales of Key Manufacturers (2015 and 2016)
Table United States Antibacterial Drug Resistance Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Antibacterial Drug Resistance Sales Share by Manufacturers
Figure 2016 Antibacterial Drug Resistance Sales Share by Manufacturers
Table United States Antibacterial Drug Resistance Revenue by Manufacturers (2015 and 2016)
Table United States Antibacterial Drug Resistance Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Antibacterial Drug Resistance Revenue Share by Manufacturers
Table 2016 United States Antibacterial Drug Resistance Revenue Share by Manufacturers
Table United States Market Antibacterial Drug Resistance Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Antibacterial Drug Resistance Average Price of Key Manufacturers in 2015
Figure Antibacterial Drug Resistance Market Share of Top 3 Manufacturers
Figure Antibacterial Drug Resistance Market Share of Top 5 Manufacturers
Table United States Antibacterial Drug Resistance Sales by States (2012-2017)
Table United States Antibacterial Drug Resistance Sales Share by States (2012-2017)
Figure United States Antibacterial Drug Resistance Sales Market Share by States in 2015
Table United States Antibacterial Drug Resistance Revenue and Market Share by States (2012-2017)
Table United States Antibacterial Drug Resistance Revenue Share by States (2012-2017)
Figure Revenue Market Share of Antibacterial Drug Resistance by States (2012-2017)
Table United States Antibacterial Drug Resistance Price by States (2012-2017)
Table United States Antibacterial Drug Resistance Sales by Type (2012-2017)
Table United States Antibacterial Drug Resistance Sales Share by Type (2012-2017)
Figure United States Antibacterial Drug Resistance Sales Market Share by Type in 2015
Table United States Antibacterial Drug Resistance Revenue and Market Share by Type (2012-2017)
Table United States Antibacterial Drug Resistance Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antibacterial Drug Resistance by Type (2012-2017)
Table United States Antibacterial Drug Resistance Price by Type (2012-2017)
Figure United States Antibacterial Drug Resistance Sales Growth Rate by Type (2012-2017)
Table United States Antibacterial Drug Resistance Sales by Application (2012-2017)
Table United States Antibacterial Drug Resistance Sales Market Share by Application (2012-2017)
Figure United States Antibacterial Drug Resistance Sales Market Share by Application in 2015
Table United States Antibacterial Drug Resistance Sales Growth Rate by Application (2012-2017)
Figure United States Antibacterial Drug Resistance Sales Growth Rate by Application (2012-2017)
Table AAIPharma Services Basic Information List
Table AAIPharma Services Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AAIPharma Services Antibacterial Drug Resistance Sales Market Share (2012-2017)
Table ANTABIO Basic Information List
Table ANTABIO Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
Table ANTABIO Antibacterial Drug Resistance Sales Market Share (2012-2017)
Table Abgentis Basic Information List
Table Abgentis Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
Table Abgentis Antibacterial Drug Resistance Sales Market Share (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Laboratories Antibacterial Drug Resistance Sales Market Share (2012-2017)
Table Absynth Biologics Basic Information List
Table Absynth Biologics Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
Table Absynth Biologics Antibacterial Drug Resistance Sales Market Share (2012-2017)
Table Achaogen Basic Information List
Table Achaogen Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
Table Achaogen Antibacterial Drug Resistance Sales Market Share (2012-2017)
Table Acino Holdings Basic Information List
Table Acino Holdings Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
Table Acino Holdings Antibacterial Drug Resistance Sales Market Share (2012-2017)
Table Aventis Pharma Basic Information List
Table Aventis Pharma Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
Table Aventis Pharma Antibacterial Drug Resistance Sales Market Share (2012-2017)
Table Austell Laboratories Basic Information List
Table Austell Laboratories Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
Table Austell Laboratories Antibacterial Drug Resistance Sales Market Share (2012-2017)
Table Assembly Biosciences Basic Information List
Table Assembly Biosciences Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
Table Assembly Biosciences Antibacterial Drug Resistance Sales Market Share (2012-2017)
Table Arpida Basic Information List
Table Demuris Basic Information List
Table Evolva Holding Basic Information List
Table ContraFect Basic Information List
Table Cerexa Basic Information List
Table GSK Basic Information List
Table InterMune Basic Information List
Table Isis Pharmaceuticals Basic Information List
Table Lyndra Basic Information List
Table Microbecide Basic Information List
Table Morphochem Basic Information List
Table Nabriva Therapeutics Basic Information List
Table NanoSafe Coatings Basic Information List
Table Novexel Basic Information List
Table Osel Basic Information List
Table PENDOPHARM Basic Information List
Table Pfizer Basic Information List
Table VenatoRx Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antibacterial Drug Resistance
Figure Manufacturing Process Analysis of Antibacterial Drug Resistance
Figure Antibacterial Drug Resistance Industrial Chain Analysis
Table Raw Materials Sources of Antibacterial Drug Resistance Major Manufacturers in 2015
Table Major Buyers of Antibacterial Drug Resistance
Table Distributors/Traders List
Figure United States Antibacterial Drug Resistance Production and Growth Rate Forecast (2017-2022)
Figure United States Antibacterial Drug Resistance Revenue and Growth Rate Forecast (2017-2022)
Table United States Antibacterial Drug Resistance Production Forecast by Type (2017-2022)
Table United States Antibacterial Drug Resistance Consumption Forecast by Application (2017-2022)
Table United States Antibacterial Drug Resistance Sales Forecast by States (2017-2022)
Table United States Antibacterial Drug Resistance Sales Share Forecast by States (2017-2022)